HealthCap — 2023 Investments
1 investments dated 2023 · listed companies and verified rows first · show all
Aro Biotherapeuticsarobiotx.comin𝕏Nov 2023
Aro Biotherapeutics develops tissue-targeted genetic medicines using a proprietary protein technology called Centyrins.
BiotechHealthtechPhiladelphia, US
Karyn O'Neil(Executive Officer, Director)Susan Dillon(Founder)inMark V. Laurenzi(Executive Officer)
BoardElizabeth Anderson(Director)Bruce Peacock(Director)
Co-investorsAvego BioScience CapitalAgent CapitalBiotechnology Value FundCowen Healthcare InvestmentsJohnson & Johnson Innovation – JJDCNorthpond Ventures
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.